Clinical Trial Update: Efficacy and Mechanism of Action of Methenamine Hippurate (Hiprex™) in Women With Recurring Urinary Tract Infections. [Phase 4]

View source ↗

Summary

Phase 4 study evaluating methenamine hippurate (Hiprex) for women with recurring urinary tract infections was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Hiprex (methenamine hippurate)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Urinary Tract Infections | Phase 4 | Status: TERMINATED | Results posted: 2026-02-24